Volume 375| Issue 6578| 21 Jan 2022
SARS-CoV-2 vaccine protection and deaths among US veterans during 2021
Barbara A. Cohn, Piera M. Cirillo, Caitlin C. Murphy, Nickilou Y. Krigbaum, Arthur W. Wallace
04 Nov 2021: 331-336
Vaccine protection against SARS-CoV-2 infection declined through August 2021 as the Delta variant emerged in the United States. We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine effectiveness against infection (VE-I) and death (VE-D) by vaccine type in 780,225 veterans in the Veterans Health Administration, covering 2.7% of the US population.